189 related articles for article (PubMed ID: 24886814)
1. Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma.
Zhang Y; Ren H; Wang L; Ning Z; Zhuang Y; Gan J; Chen S; Zhou D; Zhu H; Tan D; Zhang H
Int J Mol Sci; 2014 May; 15(6):9718-34. PubMed ID: 24886814
[TBL] [Abstract][Full Text] [Related]
2. Significance of tumor associated tissue eosinophilia and other inflammatory cell infiltrate in early esophageal squamous cell carcinoma.
Ohashi Y; Ishibashi S; Suzuki T; Shineha R; Moriya T; Satomi S; Sasano H
Anticancer Res; 2000; 20(5A):3025-30. PubMed ID: 11062718
[TBL] [Abstract][Full Text] [Related]
3. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma.
Guo SJ; Lin DM; Li J; Liu RZ; Zhou CX; Wang DM; Ma WB; Zhang YH; Zhang SR
Dis Esophagus; 2007; 20(2):107-16. PubMed ID: 17439593
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.
Zhu Y; Li M; Bo C; Liu X; Zhang J; Li Z; Zhao F; Kong L; Yu J
Cancer Immunol Immunother; 2017 Mar; 66(3):343-354. PubMed ID: 27915370
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Wang J; Jia Y; Wang N; Zhang X; Tan B; Zhang G; Cheng Y
J Transl Med; 2014 Jan; 12():7. PubMed ID: 24397835
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neutrophil-to-lymphocyte ratio in peripheral blood and pathological tissue in patients with esophageal squamous cell carcinoma.
Guo Q; Shao Z; Xu D; Fan L; Xiong H; Ding X; You C; Zhang L
Medicine (Baltimore); 2020 Jul; 99(29):e21306. PubMed ID: 32702926
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
Yang X; Wang L; Du H; Lin B; Yi J; Wen X; Geng L; Du X
Medicine (Baltimore); 2021 Jan; 100(3):e24328. PubMed ID: 33546064
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of SPARC in esophageal squamous cell carcinoma.
Chen Y; Zhang Y; Tan Y; Liu Z
Biochem Biophys Res Commun; 2017 Oct; 492(2):184-191. PubMed ID: 28818666
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
13. A study of multinucleated giant cells in esophageal cancer.
Wang H; Zhou J; Li J; Geng Y; Meng P; Ma C; Zhu Z; Zhang W; Hong L; Quan Y; Wei J; Huang Q; Zhou Y; Su Z; Zhu X; Chen C; Chen S; Gu J
Clin Immunol; 2021 Jan; 222():108600. PubMed ID: 33197619
[TBL] [Abstract][Full Text] [Related]
14. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
15. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis.
Chen FJ; Sun M; Li SQ; Wu QQ; Ji L; Liu ZL; Zhou GZ; Cao G; Jin L; Xie HW; Wang CM; Lv J; De W; Wu M; Cao XF
Mol Carcinog; 2013 Nov; 52(11):908-15. PubMed ID: 24151120
[TBL] [Abstract][Full Text] [Related]
16. Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.
Jiang D; Liu Y; Wang H; Wang H; Song Q; Sujie A; Huang J; Xu Y; Zeng H; Tan L; Hou Y; Xu C
Sci Rep; 2017 Mar; 7():44823. PubMed ID: 28322245
[TBL] [Abstract][Full Text] [Related]
17. Interrelations of clinicopathological variables, local immune response and prognosis in esophageal squamous cell carcinoma.
Ma Y; Xian M; Li J; Kawabata T; Okada S
APMIS; 1999 May; 107(5):514-22. PubMed ID: 10335956
[TBL] [Abstract][Full Text] [Related]
18. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
